Colchicine for Excess ASCVD Risk in IMIDs? Experts Weigh In Colchicine for Excess ASCVD Risk in IMIDs? Experts Weigh In

Experts assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic cardiovascular disease (ASCVD) in patients with immune-mediated inflammatory diseases (IMIDs).MDedge News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Rheumatology News Source Type: news